about
Heterologous expression of human cytochrome P450 (CYP) 2C19 in Escherichia coli and establishment of RP-HPLC method to serve as activity marker.In vitro approaches to investigate cytochrome P450 activities: update on current status and their applicability.Khat (Catha edulis) and Obesity: A Scoping Review of Animal and Human Studies.Functional role of Ile264 in CYP2C8: mutations affect haem incorporation and catalytic activity.In vitro and in silico Approaches to Study Cytochrome P450-Mediated Interactions.Cytochrome P450 2W1 (CYP2W1) - ready for use as the biomarker and drug target for cancer?In Vitro Functional Characterisation of Cytochrome P450 (CYP) 2C19 Allelic Variants CYP2C19*23 and CYP2C19*24.The current understanding of the interactions between nanoparticles and cytochrome P450 enzymes - a literature-based reviewEffect of 95% Ethanol Khat Extract and Cathinone on in vitro Human Recombinant Cytochrome P450 (CYP) 2C9, CYP2D6, and CYP3A4 ActivityIn vitro effect of important herbal active constituents on human cytochrome P450 1A2 (CYP1A2) activityCytochrome P450 2C9-natural antiarthritic interactions: Evaluation of inhibition magnitude and prediction from in vitro dataSite-Directed Mutagenesis of Cytochrome P450 2D6 and 2C19 Enzymes: Expression and Spectral Characterization of Naturally Occurring Allelic VariantsCytochrome P450 genotype-guided drug therapies: An update on current statesCytochrome P450 4B1 (CYP4B1) as a target in cancer treatmentFunctional and structural characterisation of common cytochrome P450 2D6 allelic variants-roles of Pro34 and Thr107 in catalysis and inhibitionCis-9, Trans-11 Conjugated Linoleic Acid Reduces Phosphoenolpyruvate Carboxykinase Expression and Hepatic Glucose Production in HepG2 Cells
P50
Q34578152-4EA88E94-93B7-48DB-9E89-1E37AADE2345Q38107523-0273E0C9-2EE3-47AE-B2BB-FEDF856409ECQ38792533-E35F0940-CE9B-40C7-88DD-DB9E470D1696Q46522892-DA4C30E4-DED8-47B1-A1C5-46DA4E00485BQ49957942-F3097A63-80B6-4879-8694-6575C9B6F700Q50485616-22DE4759-50D4-4424-AF8E-27768B53AB7AQ51541424-A3A7783B-1396-4B36-9F2C-09D571289DDBQ57158237-28082F42-E913-4C39-9051-87C50EB80B0AQ57283682-A8346896-2FF2-4F7C-902B-8C7DD57EED9FQ61953146-8AD1939B-B432-4953-9A7F-8EAABDF41860Q87904411-8C18D009-F8E9-460B-8E6A-E2FECF846C01Q88013488-367FF40E-16A0-433D-92F0-194B824077F3Q88955340-F505850A-F8C3-4D04-89FB-F20DD4E522ADQ89699115-E131DF79-F4B8-40AE-88FC-62AEC21C5A77Q91532484-8B9CFCA5-8BD8-4CE1-ADC9-4DA5712AB1A2Q92261837-55E47020-DBE9-4CCA-8338-01C58EA48BFD
P50
description
investigador
@es
researcher
@en
name
Yan Pan
@en
type
label
Yan Pan
@en
prefLabel
Yan Pan
@en
P31
P496
0000-0002-4546-2351